Structural requirements for the stability of novel cephalosporins to AmpC β-lactamase based on 3D-structure

We propose novel structural requirements that FR259647 derivatives with lower probability of entry into the binding pocket of AmpC β-lactamase are more stable to the enzyme. AmpC β-lactamase is one of the leading causes of Pseudomonas aeruginosa ( P. aeruginosa) resistance to cephalosporins. FR25964...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2008-03, Vol.16 (5), p.2261-2275
Hauptverfasser: Murano, Kenji, Yamanaka, Toshio, Toda, Ayako, Ohki, Hidenori, Okuda, Shinya, Kawabata, Kohji, Hatano, Kazuo, Takeda, Shinobu, Akamatsu, Hisashi, Itoh, Kenji, Misumi, Keiji, Inoue, Satoshi, Takagi, Tatsuya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We propose novel structural requirements that FR259647 derivatives with lower probability of entry into the binding pocket of AmpC β-lactamase are more stable to the enzyme. AmpC β-lactamase is one of the leading causes of Pseudomonas aeruginosa ( P. aeruginosa) resistance to cephalosporins. FR259647 is a cephalosporin having a novel pyrazolium substituent at the 3-position and exhibits excellent activity (MIC = 1 μg/mL) against the AmpC β-lactamase overproducing P. aeruginosa FP1380 strain in comparison with the third-generation cephalosporins FK518 [ Abstracts of Papers, 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, October 21–24, 1990, Abs. 454; Abstracts of Papers, 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, October 21–24, 1990, Abs. 455; Abstracts of Papers, 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, October 21–24, 1990, Abs. 456; Abstracts of Papers, 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, October 21–24, 1990, Abs. 457] (MIC = 16 μg/mL) and ceftazidime (CAZ) (MIC = 128 μg/mL). The stability of FR259647 and FK518 to AmpC β-lactamase was evaluated using MIC assays against both the P. aeruginosa PAO1 strain and a PAO1 mutant strain overproducing AmpC β-lactamase as a differential assay, which indicates that the main difference derives from their stability to AmpC β-lactamase. A structural analysis using computer simulations indicated that the difference in stability may be due to steric hindrance of the 3-position substituents causing differential affinity. This steric hindrance may disturb entry of the cephalosporins into the binding pocket. We predicted the possibility of inhibition of entry as a potential means of enhancing stability by conformational analysis. In order to validate this speculation, novel FR259647 derivatives 4– 9 were designed, calculated, synthesized, and evaluated. As a result, we demonstrated that their probability of entry correlated with the MIC ratio of the mutant strain to the parent strain and supports the validity of our model.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2007.11.074